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1. Introduction {#jia225310-sec-0005}
===============

Increased HIV testing of high‐risk groups and linkage of those who are HIV positive to antiretroviral treatment (ART) is needed to achieve the 95‐95‐95 objectives by 2030 (95% of people living with HIV (PLHIV) diagnosed; 95% of diagnosed people on ART; and 95% of all people receiving ART having viral suppression) [1](#jia225310-bib-0001){ref-type="ref"}. The Cameroon Population‐based HIV Impact Assessment, a 2017 household‐based survey, estimated that 500,000 PLHIV aged 15 to 64 years residing in Cameroon, which had an HIV adult prevalence of 3.7% and 53% of PLHIV, were unaware of their status [2](#jia225310-bib-0002){ref-type="ref"}. HIV transmission in Cameroon primarily occurs through heterosexual sex, and women suffer a disproportionate burden of infection [3](#jia225310-bib-0003){ref-type="ref"}. Assisted partner notification services (aPNS), previously called contact tracing, have been implemented as a public health intervention to identify individuals most at risk of HIV infection, screen those who consent and link those who are HIV positive to treatment [4](#jia225310-bib-0004){ref-type="ref"}, [5](#jia225310-bib-0005){ref-type="ref"}.

Contact tracing has been integrated into public health efforts to control sexually transmitted infections, including HIV, in some parts of the United States and Europe for a long time [6](#jia225310-bib-0006){ref-type="ref"}, [7](#jia225310-bib-0007){ref-type="ref"}. However, it has not traditionally been part of HIV prevention and care in low‐ and middle‐income nations. Instead, most clinicians and public health programmes have counselled patients to notify sexual partners/contact persons (CPs) by themselves -- a form of passive referral -- and the success of this approach has not been consistently measured [8](#jia225310-bib-0008){ref-type="ref"}. Based on a contact tracing model used in the North Carolina Department of Health, which was derived from tools developed by the United States Centers for Disease Control and Prevention (CDC) in the 1990s, the Cameroon Baptist Convention Health Services (CBCHS) initiated aPNS in 2007. To the best of our knowledge, this was the first large‐scale implementation of its kind in Cameroon and in SSA. In December 2016, the World Health Organization (WHO) released new guidelines on HIV self‐testing and partner notification [9](#jia225310-bib-0009){ref-type="ref"} based on evidence from clinical trials and observational studies, mostly from SSA countries such as Kenya, Malawi, Mozambique and Cameroon [10](#jia225310-bib-0010){ref-type="ref"}, [11](#jia225310-bib-0011){ref-type="ref"}, [12](#jia225310-bib-0012){ref-type="ref"}, [13](#jia225310-bib-0013){ref-type="ref"}. aPNS is now acknowledged as an effective strategy in the HIV epidemic control [4](#jia225310-bib-0004){ref-type="ref"}, [14](#jia225310-bib-0014){ref-type="ref"}.

In this article, we describe the initiation, implementation and programmatic achievements of the CBCHS aPNS programme from its inception in 2007 through 2015.

2. Methods {#jia225310-sec-0006}
==========

2.1. Programme initiation and implementation {#jia225310-sec-0007}
--------------------------------------------

CBCHS started aPNS in 2007 as a public health intervention without support from national and international partners. At that time, WHO guidelines did not recommend the routine provision of the strategy. The programme relied entirely on CBCHS frontline health advisors (HAs), who were trained using training materials adapted from CDC contact tracing tools. The first cohort of 15 HAs trained for the programme included HIV educators, laboratory technicians, nurses, social workers and chaplains, who provided aPNS in addition to their usual jobs.

aPNS began in one CBCHS health facility located in the Northwest Region of Cameroon and expanded to 15 other CBCHS facilities in five of the ten regions by the end of 2015 through technical assistance and financial support received from the Elizabeth Glazer Pediatric AIDS Foundation, Centers for AIDS Research at the University of Washington and the University of North Carolina, after the programme documented early promising results.

In 2013, aPNS were integrated into other HIV and reproductive health services in 22 non‐CBCHS facilities selected as pilot sites for the prevention of mother to child transmission (PMTCT) programme Option B+ strategy before Cameroon\'s national scale‐up of Option B+.

2.2. Programme procedures {#jia225310-sec-0008}
-------------------------

HAs were trained in the effective use and interpretation of the HIV rapid diagnostic test (Determine HIV 1 and 2), data collection, and the management of social harms, including intimate partner violence (IPV) and partnership dissolution occurring after index persons (IPs) received aPNS. If the HIV test performed by the HA was positive, the HA referred the CP to a health facility for confirmatory testing. HAs counselled HIV‐positive clients on how to reduce their risk of HIV transmission and HIV negative CPs on preventing HIV acquisition. HAs followed up participants, and engaged supervisors, pastors and social workers when they suspected or identified social harms, with the intention of minimizing the risk of physical, sexual and psychological harm. At the end of the training, HAs agreed to ensure the confidentiality of clients, both verbally and by signing a non‐disclosure agreement (see Appendix [S1](#jia225310-sup-0001){ref-type="supplementary-material"}).

In providing aPNS, CPs were the primary target of HAs, although in some instances, the HAs proposed and tested other household contacts including children after obtaining their verbal consent. Data from this sub‐population were not systematically collected and are therefore not included in this analysis.

Whenever possible and after seeking verbal consent, HAs started aPNS on the same day that the IP was diagnosed HIV positive. HAs offered IPs three options to notify their sex partners [9](#jia225310-bib-0009){ref-type="ref"}:

### 2.2.1. A provider or active referral {#jia225310-sec-0009}

The HA with consent from the IP takes the responsibility to confidentially contact CP(s) identified by the IP and to notify CP(s) of their exposure to HIV.

### 2.2.2. Contract, conditional, hybrid or negotiated referral {#jia225310-sec-0010}

The HA and the IP make a contract, whereby the IP agrees to disclose his/her HIV status to CP(s) and encourages the CPs to test within a specified period, usually within two weeks. If the CP(s) do not test during that period, the provider contacts the CP(s) directly.

### 2.2.3. Patient referral {#jia225310-sec-0011}

The HA counsels the IP, often using role plays, to disclose their HIV status to CP(s) and the IP then encourages the partners to come to a facility for testing.

HAs and IPs agreed together on the best approach to inform CPs. However, the programme promoted provider referral because direct communication between HAs and CPs yielded more positive results compared to other options. Under provider referral, HAs notified CPs of their potential exposure to HIV either in person or by telephone. HAs pre‐test counselled CPs and offered them HIV testing either in the health facility, their home or they were referred to another health facility for testing. HAs followed up through regular phone calls to confirm that the CP(s) had tested for HIV and recorded the test results in an aPNS register and kept it in a locked office. Finally, HAs provided education on HIV prevention and referred IPs and HIV positive CPs to HIV care and treatment services. HAs documented referral of HIV positive CPs, but did not systematically ensure enrolment, retention in care and adherence to ART due to lack of resources and training.

2.3. Data collection, monitoring and evaluation {#jia225310-sec-0012}
-----------------------------------------------

HAs obtained verbal consent prior to data collection by explaining the purpose and content of aPNS to both IPs and CPs, and reiterated that they were free to either accept or decline aPNS without affecting access to other services at the facility. Information collected during face‐to‐face or phone interviews was recorded on interview forms and stored in a secure place at a health facility or in the community. Although interview forms varied throughout the evaluation period to capture critical information or to streamline the process, all records included information on basic demographics, sexual risk behaviour, HIV testing history, sexual partner details and aPNS outcomes. These data were used to guide counselling, identify partners requiring testing and offer monitoring and evaluation data.

HAs transferred data from interview forms into aPNS registers secured within each health facility. Monthly facility reports of aggregate registry data were then sent to the central CBCHS aPNS programme office where they were merged into the overall aPNS workload reports. HAs also sent completed interview forms to the central aPNS programme office periodically for entry into an Epi Info database. Incomplete interview forms were retained in participating facilities until follow‐up data were recorded although many were never forwarded to the central aPNS programme office for final data entry. Although the Epi Info database lacks complete workload data, it provides more detailed analyses for programme monitoring and evaluation. The computer databases were password protected with access limited to programme staff who have signed the confidentiality form.

In 2014 to 2015, the CBCHS programme received funding to allow HAs to actively follow‐up on IPs 30 days after their initial interview, and assess social harms and IPV associated with aPNS. At these follow‐up interviews, the HAs recorded IPs responses on the same interview form used at the initial visit. The results of both the initial and follow‐up interviews were then sent to the central office for entry into the Epi Info database.

2.4. Statistical analysis {#jia225310-sec-0013}
-------------------------

We report two analyses. First, using aggregate data from registries between 2007 and 2015, we report total programme outcomes, including the number of IPs receiving aPNS, the number and percentage of CPs reported, notified, tested, and referred for care and treatment. For this analysis, we also report the number of IPs needed to interview (NNTI) to identify one CP with HIV, that is, number of IPs receiving aPNS divided by the number of CPs testing HIV positive. Second, using data from interview forms entered in an Epi‐Info database from 2014 to 2015, we reported the characteristics of IPs and CPs, methods used to notify CPs and the occurrence of social harms, including those described on follow‐up. Continuous predictor and outcome variables were summarized using the median and interquartile range (IQR), while categorical variables were summarized using percentages. The analysis was conducted using Stata 14.0 (StataCorp, College Station, TX, USA).

2.5. Ethical considerations {#jia225310-sec-0014}
---------------------------

Ethical approval was sought and obtained from the CBCHS Institutional Review Board (IRB) before the programme inception. The IRB deemed aPNS to be a public health intervention, which should be monitored and evaluated, and did not consider it research.

3. Results {#jia225310-sec-0015}
==========

3.1. Overall programme aPNS achievements {#jia225310-sec-0016}
----------------------------------------

Figure [1](#jia225310-fig-0001){ref-type="fig"} shows the flow chart of aPNS in Cameroon from inception in 2007 through December 2015. Overall, 18,730 IPs consenting to receive aPNS identified 21,057 CPs to notify and test. Of these CPs, 12,867 (61%) learned of their exposure to HIV, 9202 (44% of all CPs and 71% of notified CPs) tested for HIV and 4764 (23% of all CPs, 37% of notified CPs and 52% of tested CPs) tested HIV positive. The NNTI to identify one CP with HIV infection was 3.9.

![**Assisted partner notification services flow chart of aggregate data from 2007 to 2015 (percentages throughout use denominators from the box in the preceding step).**](JIA2-22-e25310-g001){#jia225310-fig-0001}

Table [1](#jia225310-tbl-0001){ref-type="table"} presents the annual programme data from 2007 to 2015. The majority of the IPs were women (68%) while the majority of CPs were men (67%). After an initial period of scale‐up from 2007 to 2009, the number of IPs receiving aPNS varied from 2061 in 2011 to 3030 in 2014. The annual contact/index was stable throughout the programme, ranging from 1.1 to 1.3. However, the programme\'s success identifying CPs was variable, peaking in 2010 when 969 CPs tested HIV positive and the NNTI varied from 2.7 in 2010 to 5.5 in 2015.

###### 

Number of index cases and contact persons (CPs) receiving assisted partner notification services per year, and programme outcomes, 2007 to 2015, derived from aggregate data

                                                           2007   2008        2009        2010        2011        2012        2013        2014        2015        Total
  -------------------------------------------------------- ------ ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ---------------
  Index persons (IPs)                                      227    1610        2174        2587        2061        2409        2439        3030        2193        18,730
  IPs male (%)[a](#jia225310-note-0001){ref-type="fn"}     --     464 (29)    713 (33)    873 (34)    679 (33)    775 (32)    806 (33)    766 (25)    790 (36)    5866 (31.7)
  IPs female (%)[a](#jia225310-note-0001){ref-type="fn"}   --     1146 (71)   1461 (67)   1713 (66)   1382 (67)   1634 (68)   1633 (67)   2264 (75)   1403 (64)   12,636 (68.3)
  CPs                                                      278    1701        2384        2812        2476        3041        2710        3283        2372        21,057
  CPs male (%)[a](#jia225310-note-0001){ref-type="fn"}     --     1182 (69)   1616 (68)   1899 (67)   1593 (64)   2038 (67)   1773 (65)   2404 (73)   1466 (62)   13,971 (67.2)
  CPs female (%)[a](#jia225310-note-0001){ref-type="fn"}   --     519 (31)    768 (32)    913 (33)    883 (36)    1003 (33)   937 (35)    879 (27)    906 (38)    6808 (32.8)
  Number of named CP per IP                                1.2    1.1         1.1         1.1         1.2         1.3         1.1         1.1         1.1         1.1
  CPs notified                                             167    1309        1742        2184        1416        1627        1336        1981        1105        12,867
  CPs tested                                               110    1004        1477        1681        808         1139        863         1339        781         9202
  CPs HIV positive                                         55     557         688         969         446         588         470         592         399         4764
  CPs HIV positive referred to care and treatment          0      37          90          633         302         587         470         591         399         3112
  NNTI[b](#jia225310-note-0001){ref-type="fn"}             4.1    2.9         3.2         2.7         4.6         4.1         5.2         5.1         5.5         3.9

^a^Sex distribution of IPs and CPs not available for 2007; ^b^NNTI: number of IPs needed to interview to identify one CP with HIV.
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3.2. Notification, HIV testing, and referral to care and treatment of CPs {#jia225310-sec-0017}
-------------------------------------------------------------------------

Figure [2](#jia225310-fig-0002){ref-type="fig"} presents data on trends in the number of CPs identified, tested, and diagnosed with HIV from 2007 to 2015. A total of 12,867 CPs (61.1%) were notified. After pre‐counselling sessions, 9202 (71.5%) of them accepted and received HIV testing services (HTS) (Table [1](#jia225310-tbl-0001){ref-type="table"}). From 2011 to 2015, the average percentage of CPs notified per year was 53.4% with the lowest level of 47% in 2015.

![**Number of contact persons (CPs) per year and number of CPs achieving each assisted partner notification services, 2007 to 2015. (Percentages above bars are the percentage of CPs with each outcome.)**](JIA2-22-e25310-g002){#jia225310-fig-0002}

The overall HIV prevalence was 51.7% among the 9202 CPs who were tested. The highest HIV prevalence was recorded in 2010 with 58% (Figure [2](#jia225310-fig-0002){ref-type="fig"}). Overall, 66% of HIV positive CPs were referred to HIV care and treatment. Referral increased each year between 2007 and 2012, and from 2012 onward, all HIV positive CPs were referred to care (Figure [2](#jia225310-fig-0002){ref-type="fig"}).

3.3. Demographic characteristics of IPs and CPs: sub‐set data from 2014 to 2015 {#jia225310-sec-0018}
-------------------------------------------------------------------------------

Information on interview forms from 1261 IPs and 1357 CPs who were followed up was entered into the Epi Info database in 2014 to 2015 and analysed. Almost all CPs (95.6%) identified by IPs were notified of their exposure. The socio‐demographic characteristics of IPs and CPs are presented in Table [2](#jia225310-tbl-0002){ref-type="table"}. The median age for both groups was 36 years (IQR: 30 to 43). The majority of IPs (63.8%) were female, married (52%) and 70.1% were seen in a rural facility. On follow‐up, most IPs had enrolled in an HIV care clinic with 72.6% having a CD4 count and 59.7% receiving ART. During 2014 to 2015, 5223 IPs received aPNS, but only 1261 had follow‐up data entered into the Epi Info database.

###### 

Demographic and HIV testing characteristics for index persons (IPs) and contact persons (CPs)

                                      IPs N = 1261   
  ----------------------------------- -------------- ------
  Demographic characteristics IPs                    
  Gender                                             
  Female                              805            63.8
  Male                                456            36.2
  Marital status                                     
  Single                              317            25.1
  Married monogamous                  603            47.9
  Married polygamous                  53             4.2
  Divorced                            124            9.8
  Widow/widower                       109            8.6
  Missing                             54             4.3
  Sites                                              
  Rural                               884            70.1
  Urban                               376            29.8
  Other (not specified)               1              0.1
  HIV care outcomes IPs                              
  CD4 count done at diagnosing site                  
  Yes                                 916            72.6
  No                                  32             2.5
  Missing                             313            24.8
  IPs on anti‐retroviral therapy                     
  Yes                                 753            59.7
  No                                  185            14.7
  Missing                             323            25.6

                                       CPs N = 1357   
  ------------------------------------ -------------- ------
  Demographic characteristics of CPs                  
  Gender                                              
  Male                                 832            61.3
  Female                               515            38.0
  Missing                              10             0.7
  Relationship with IPs                               
  Wife/husband                         773            57.0
  Girlfriend/boyfriend                 549            40.5
  Other                                11             0.8
  Missing                              24             1.8
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3.4. HIV care outcomes CPs notified: sub‐set data from 2014 to 2015 {#jia225310-sec-0019}
-------------------------------------------------------------------

Of the 1357 identified CPs, 1224 (90.2%) were traced for notification, of whom 1170 (95.6%) were successfully notified (Table [3](#jia225310-tbl-0003){ref-type="table"}). IPs elected to notify 43.7% via patient referral and elected to use provider referral for 44.3%. Most partners were notified in‐person (71.1%). A total of 784 CPs were tested, of whom 41.6% (326/784) were HIV positive. This included 157 persons newly diagnosed with HIV infection and 169 persons with a prior HIV diagnosis. Of the 326 HIV positive sexual partners, 43.2% had a CD4 count done and 24.5% were initiated on ART.

###### 

Characteristics and HIV care outcomes of contact persons (CPs) notified

                                                   CPs N = 1224   
  ------------------------------------------------ -------------- ------
  CPs HIV characteristics                                         
  CPs notified                                                    
  Yes                                              1170           95.6
  No                                               21             1.7
  CP was dead                                      2              0.2
  Missing                                          31             2.5
  Method of notification                                          
  Passive referral                                 535            43.7
  Provider referral                                542            44.3
  Negotiated referral                              62             5.1
  Tested and diagnosed same time as index person   38             3.1
  Missing                                          47             3.8
  Phone or in‐person notification                                 
  In‐person                                        870            71.1
  Phone                                            293            23.9
  Other                                            6              0.5
  Missing                                          55             4.5
  CPs tested for HIV                                              
  Yes                                              784            64.1
  No                                               235            19.2
  Unknown                                          126            10.3
  Missing                                          79             6.5

                                      n = 784   
  ----------------------------------- --------- ------
  HIV testing outcomes                          
  HIV status of CPs                             
  Newly diagnosed HIV positive        157       20.0
  Previously diagnosed HIV positive   169       21.6
  Tested HIV negative                 458       58.4

                                                        n = 326   
  ----------------------------------------------------- --------- ------
  HIV Care outcomes for HIV positive CPs on follow‐up             
  CD4 count done at diagnosing site                               
  Yes                                                   141       43.2
  No                                                    26        8.0
  Missing                                               159       48.8
  CPs on anti‐retroviral therapy                                  
  Yes                                                   80        24.5
  No                                                    41        12.6
  Missing                                               205       62.9
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3.5. aPNS and social harms: sub‐set data from 2014 to 2015 {#jia225310-sec-0020}
----------------------------------------------------------

Of the 1357 IPs enrolled, 267 (19.7%) reported a history of social harms before receiving aPNS from the sexual partners they mentioned (female IP: 24.2%, male IPs: 15.8%) with 7.4% of the IPs (101/1357) fearing for IPV from their sexual partners. Among those with a history of IPV, 43.5% (116/267) had experienced such harm in the three months before enrolment in the aPNS programme.

Adverse outcomes among IPs after receipt of aPNS were infrequent and many of them have not been directly related (Table [4](#jia225310-tbl-0004){ref-type="table"}). On follow‐up, 61 IPs reported subsequent adverse outcomes from their sexual partners (61/976, 6.3%), all of them involving partnership dissolution with 41.0% (25/61) of the remaining separate from their partners for at least two years (Table [4](#jia225310-tbl-0004){ref-type="table"}). Loss of financial support and physical IPV accounted for 1.5% and 1.1% of adverse outcomes among IPs after receipt of aPNS respectively. Overall, 11 (1.1%) of 976 persons for whom data was available reported physical IPV following their HIV diagnosis; and of these, three attributed the violence to aPNS provided by an HA. None required hospitalization.

###### 

Adverse outcomes reported among index persons (IPs) at follow‐up

                                                                                  IPs N = 976   
  ------------------------------------------------------------------------------- ------------- ------
  Adverse outcomes reported at follow‐up                                                        
  Any adverse outcome (IPV, partnership dissolution, loss of financial support)   61/976        6.3
  Partnership ended since testing HIV positive                                    61/976        6.3
  Are you still separated from them?                                                            
  Yes                                                                             25/61         41.0
  Duration of separation                                                                        
  Less than two years                                                             2/25          8.0
  Two years                                                                       14/25         56.0
  Three years                                                                     6/25          24.0
  Greater than three years                                                        3/25          12.0
  No                                                                              10/61         16.4
  Missing                                                                         26/61         42.6
  Contact person (CP) left because IP tested HIV positive                                       
  Yes                                                                             14/61         23.0
  No                                                                              6/61          9.8
  Don\'t know                                                                     17/61         27.9
  Declined to answer                                                              2/61          3.3
  Missing                                                                         22/61         36.1
  CP stopped financial support                                                                  
  Yes                                                                             15/976        1.5
  CP stopped financial support because of HIV positive result                                   
  Yes                                                                             5/15          33.3
  No                                                                              2/15          13.3
  Don\'t know                                                                     5/15          33.3
  Missing                                                                         3/15          20.0
  No                                                                              18/976        1.8
  Never received financial support from this CP                                   15/976        1.5
  Declined to answer                                                              1/976         0.1
  Missing                                                                         12/976        1.2
  Sustained physical IPV from CPs since testing HIV+                                            
  Yes                                                                             11/976        1.1
  Physical IPV from CP because of testing HIV positive                            7/11          63.6
  Physical IPV from CP because of HA notification                                 3/11          27.3
  Reason missing                                                                  1/11          9.1
  No                                                                              29/976        3.0
  Don\'t know                                                                     15/976        1.5
  Declined to answer                                                              1/976         0.1
  Missing                                                                         5/976         0.5

IPV, intimate partner violence; HA, health advisors.
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4. Discussion {#jia225310-sec-0021}
=============

The programmatic outcomes of this large‐scale aPNS programme span nine years and demonstrate that implementation and scale‐up of aPNS were feasible in SSA with little social harm, despite limited funding. The primary benefits of aPNS are notification of individuals either at high risk of being HIV infected or those already HIV positive, facilitating confirmation of their HIV status, offering counselling, and referral services to care and treatment [4](#jia225310-bib-0004){ref-type="ref"}, [8](#jia225310-bib-0008){ref-type="ref"}, [15](#jia225310-bib-0015){ref-type="ref"}.

Most IPs were female, similar to a cluster randomized controlled trial in Kenya [10](#jia225310-bib-0010){ref-type="ref"}. Findings from a qualitative study conducted in Lesotho suggested that women have regular access to HTS through antenatal clinics and other maternal and child health‐related programmes. Also, men reported few opportunities to visit health clinics or HIV testing sites and commonly received information about HIV from mass media and friends. All participants unanimously characterized men as fearful and resistant to HIV testing [16](#jia225310-bib-0016){ref-type="ref"}. This perception matched reality in many SSA countries, where HIV testing has traditionally focused on women, and highlighted the value of aPNS for HIV case finding among men, a population often neglected in the healthcare system [17](#jia225310-bib-0017){ref-type="ref"}.

The CBCHS programme also integrated aPNS into other HIV and reproductive health services. Therefore, aPNS helped reduce the gender disparity in HIV case‐finding and referral to care and treatment services, with 67% of all CPs tested being men [17](#jia225310-bib-0017){ref-type="ref"}. Furthermore, studies suggested that male HIV‐testing was associated with increased acceptance and adherence among women attending PMTCT [18](#jia225310-bib-0018){ref-type="ref"}, [19](#jia225310-bib-0019){ref-type="ref"} and was crucial to the success of PMTCT interventions designed to promote women\'s health [20](#jia225310-bib-0020){ref-type="ref"}, [21](#jia225310-bib-0021){ref-type="ref"}.

The mean CP/IP in the CBCHS aPNS programme ranged between 1.1 and 1.3, similar to results from a pilot aPNS programme in public urban clinics in Mozambique (1.4) [12](#jia225310-bib-0012){ref-type="ref"}, but lower than that found in Kenya (1.67) [10](#jia225310-bib-0010){ref-type="ref"}. This disparity could be due to the implementation of aPNS in real‐world conditions as a public health intervention in Cameroon and to a lesser extent in Mozambique, as compared to controlled research settings in Kenya. Also, the Cameroon aPNS programme started in faith‐based health facilities, which might have biased PLHIV, either in the choice of which facility to visit or in revealing information about their CPs. The range of sexual partners reported by the IPs is not available in the data analysed for this paper, but a previous report of the CBCHS aPNS programme reported a median of four lifetime sexual partners (range, 1 to 50) and one sexual partner (range, 1 to 50) in the last three years [13](#jia225310-bib-0013){ref-type="ref"}.

HIV prevalence among CPs tested in Cameroon (51.8%) was 14 times higher than the national prevalence (3.7%), suggesting that aPNS played a key role not only in identifying PLHIV and referring them to care and treatment but also in identifying HIV‐uninfected persons in HIV‐discordant partnerships with the objective of preventing HIV transmission to the HIV uninfected partner [22](#jia225310-bib-0022){ref-type="ref"}. Although the overall referral of HIV positive CPs to HIV care and treatment services was 66%, all of HIV positive CPs were referred to HIV care and treatment five years after the programme was initiated. During the early years of aPNS implementation, access to care and treatment in Cameroon was challenging due to the high costs, a limited number of HIV treatment centres and dedicated staff, stigma and the restrictive treatment initiation criteria based on CD4 count [24](#jia225310-bib-0024){ref-type="ref"}. With increased support from international funding partners, HIV care coverage has expanded nationally with more PLHIV were referred and initiated on ART [22](#jia225310-bib-0022){ref-type="ref"}, [23](#jia225310-bib-0023){ref-type="ref"}. The proportion of CPs who initiated ART remained in care and adhered to treatment were not systematically documented and therefore not reported in this evaluation.

Our findings related to social harms associated with aPNS are largely consistent with other studies. In Kenya, less than 3% of CPs who received aPNS experienced physical IPV, while few cases of partnership dissolution were notified in Malawi and Mozambique [10](#jia225310-bib-0010){ref-type="ref"}, [11](#jia225310-bib-0011){ref-type="ref"}, [12](#jia225310-bib-0012){ref-type="ref"}. These findings from various socio‐cultural settings provided evidence that aPNS, as implemented by trained providers, results in low levels of social harms. When our programme identified cases experiencing social harms, they were managed by experienced counsellors. All aPNS are voluntary; thus, when HAs elicit a history of social harms, they should proceed cautiously and IPs should be given an opportunity to decline aPNS.

The Cameroon Ministry of Public Health recognized CBCHS\'s commitment to increasing access to testing for those at higher HIV risk through aPNS and included it in national HIV control strategies and policies in 2014. This was a bottom‐up approach in the implementation of an effective HIV prevention strategy and its success was largely due to the unwavering determination of the CBCHS leadership and dedicated personnel. The CBCHS programme was influential in the early promotion and design of aPNS interventions and training of staff in other high HIV prevalence SSA countries including Kenya and Mozambique.

aPNS implementation in Cameroon had some limitations and challenges. Throughout the programme, limited funding greatly affected coverage and staff motivation, resulting in fewer CPs notified and tested, and poor follow‐up of IPs and HIV positive CPs. Obtaining accurate information from IPs was often difficult, as some gave incorrect information on their CPs, such as wrong phone numbers or wrong home address, and did not keep to their appointments. While there were concerns that aPNS may be associated with social harms and IPV, such outcomes occurred infrequently and the aPNS programme provided support and counselling to the affected individuals when such problems arose [13](#jia225310-bib-0013){ref-type="ref"}. A few CPs threatened HAs with violence, but none of the HAs experienced physical harm or litigation. Most of the monitoring and evaluation was based on aggregate data submitted monthly by participating facilities, which precluded disaggregation for more detailed analyses. The sub‐analysis of 2014 to 2015 data included information on the follow‐up of IPs. However, these analyses were not representative of the beneficiaries of the entire programme. The aPNS programme did not have sufficient resources to more actively follow‐up the CPs who were referred to HIV care and treatment, which likely would have allowed us to determine the proportion who received ART and to better identify social harms. aPNS provides the opportunity to link both IPs and HIV positive CPs to HIV care and treatment. ART is now universally available to all PLHIV in Cameroon. The NNTI numbers reported included all HIV positive CPs, both new diagnoses and people who may have been previously tested and not yet linked to ART.

5. Conclusions {#jia225310-sec-0022}
==============

Results presented from nine years (2007 to 2015) of the implementation of aPNS as a large‐scale public health programme shows that it has been feasible in Cameroon. aPNS helped identify many PLHIV who did not know their status, who were then counselled on HIV prevention strategies if HIV negative, or referred to HIV care if HIV positive. Social harms and IPV occurred infrequently after aPNS. The HAs provided support to people experiencing social harms to mitigate long‐term adverse consequences.
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